Search Result: parkinson's
…medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease. J Neurol. 2020 Mar;267(3):860-869. https://doi.org/10.1007/s00415-020-09705-7 Do, J., McKinney, C., Sharma, P. et al. Glucocerebrosidase and its relevance to Parkinson disease….
Content Section:
Articles
…Mar 1;142(3):512-525. Whone AL, Boca M, Luz M, et al. Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s Disease. J Parkinsons Dis. 2019 Feb 26. doi: 10.3233/JPD-191576. [Epub…
Content Section:
Articles
…I, Shah B, Weir D. Alpha-Synuclein p.H50Q, a Novel Pathogenic Mutation for Parkinson’s Disease. Mov Disord. 2013;28:811-813. Bonifati V. Genetics of Parkinson’s disease-state of the art 2013. Parkinsonism and Relat…
Content Section:
Articles
…any reason and the drug calculator has now been adopted by Parkinson’s UK (available on UK Parkinson’s Excellence Network website at www.parkinsonscalculator.com). The Academy has produced a wealth of expertise…
Content Section:
Articles
…company developing disease-modifying agents for neurodegenerative disorders, announced on March 27th topline results from the Phase 2 trial with NLY01 in patients with early, untreated Parkinson’s disease (PD). The primary…
Content Section:
News Posts
…https://doi.org/10.1002/mds.23529 Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, et al. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson’s disease. Parkinsonism…
Content Section:
Articles
…Parkinson’s disease. The French Clozapine Parkinson Study Group. Lancet. 1999:353;2041-2042. https://doi.org/10.1016/S0140-6736(99)00860-0 Cummings J et al. Pimavanserin for patients with Parkinson’s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet. 2014;383:533-540,…
Content Section:
Articles
…P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation. Nat Med. 2008;14:501-3. https://doi:10.1038/nm1746 Olanow CW, Brundin P. Parkinson’s Disease and…
Content Section:
Articles
…of subcutaneously injected apomorphine for parkinsonian off-state events. Arch Neurol 2001;58:1385-92. Pahwa R, Koller WC, Trosch RM, Sherry JH; APO303 Study Investigators. Subcutaneous apomorphine in patients with advanced Parkinson’s disease:…
Content Section:
Articles